B-Flexion

B-Flexion company information, Employees & Contact Information

Explore related pages

Related company profiles:

B-FLEXION is a private, entrepreneurial investment firm that partners with sophisticated capital to meet the shared goal of delivering exceptional value over generations, while also contributing positively to society. With offices across Europe and in the US, B-FLEXION invests in – and partners with – asset managers across sectors including Private Equity, Venture Capital, Infrastructure, Technology, Real Estate, Hedge Funds, Public and Private Credit, and Public Securities. It also continues to drive expansion by growing operating businesses in transformative industries. In keeping with – and building upon – its heritage, these are principally in the fields of Life Sciences, Healthcare Services and Digital Health.

Company Details

Employees
137
Address
Them)
Industry
Investment Management
NAICS
Other Financial Investment Activities
Portfolio Management
All Other Financial Investment Activities
Trust, Fiduciary, and Custody Activities
Miscellaneous Financial Investment Activities
Keywords
Digital Health..
Looking for a particular B-Flexion employee's phone or email?

B-Flexion Questions

News

Seminar to discuss impact of AI and tech on fund industry - Bailiwick Express

Seminar to discuss impact of AI and tech on fund industry Bailiwick Express

Bertarelli investment group boss gives up raft of roles - Citywire

Bertarelli investment group boss gives up raft of roles Citywire

Allergy Partners Appoints Chris Kane As CEO - citybiz

Allergy Partners Appoints Chris Kane As CEO citybiz

Watkins Advises B-Flexion on Sale of Affidea Group - Latham & Watkins LLP

Watkins Advises B-Flexion on Sale of Affidea Group Latham & Watkins LLP

Boston Pharmaceuticals Announces Former NIH Director, Dr. Elias Zerhouni, As the New Chair of Its Board of Directors - Business Wire

Boston Pharmaceuticals Announces Former NIH Director, Dr. Elias Zerhouni, As the New Chair of Its Board of Directors Business Wire

Corium Pharma Solutions Appoints Suzanne Hinchliffe As Chief People Officer - citybiz

Corium Pharma Solutions Appoints Suzanne Hinchliffe As Chief People Officer citybiz

GBL Said Near to $1.7 Billion Affidea Deal With Swiss Tycoon - Bloomberg.com

GBL Said Near to $1.7 Billion Affidea Deal With Swiss Tycoon Bloomberg.com

Peter Sanborn Joins Arbor Ventures as General Partner - Business Wire

Peter Sanborn Joins Arbor Ventures as General Partner Business Wire

EV startup Volta Trucks in advanced talks to secure €250m funding - Techarenan.news

EV startup Volta Trucks in advanced talks to secure €250m funding Techarenan.news

Boston Pharmaceuticals Appoints Juan Carlos Lopez-Talavera, MD, PhD, as Acting Chief Medical Officer - citybiz

Boston Pharmaceuticals Appoints Juan Carlos Lopez-Talavera, MD, PhD, as Acting Chief Medical Officer citybiz

Swiss billionaire-linked fund sets up two new Irish entities - The Irish Independent

Swiss billionaire-linked fund sets up two new Irish entities The Irish Independent

Boston Pharmaceuticals Presents Data at NASH-TAG 2024 Demonstrating Low Immunogenicity Over Time With Long-acting FGF21 Analogue, BOS-580, for MASH - Business Wire

Boston Pharmaceuticals Presents Data at NASH-TAG 2024 Demonstrating Low Immunogenicity Over Time With Long-acting FGF21 Analogue, BOS-580, for MASH Business Wire

Boston Pharmaceuticals Appoints Dr. Sophie Kornowski as Chair of its Board - citybiz

Boston Pharmaceuticals Appoints Dr. Sophie Kornowski as Chair of its Board citybiz

Gurnet Point Capital Appoints Stacey Seltzer as Partner - Business Wire

Gurnet Point Capital Appoints Stacey Seltzer as Partner Business Wire

Top B-Flexion Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant